National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Available at: www.seer.cancer.gov (accessed November1, 2016).
2.
SmithLH, DanielsenB, AllenME, CressR. 2003. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol, 189:1128–1135.
3.
MazzaferriEL. 2011. Approach to the pregnant patient with thyroid cancer. J Clin Endocrinol Metab, 96:265–272.
4.
HirschD, LevyS, TsvetovG, WeinsteinR, LifshitzA, SingerJ, Shraga-SlutzkyI, Grozinski-GlasbergS, ShimonI, BenbassatC. 2010. Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid, 20:1179–1185.
5.
MessutiI, CorvisieriS, BardesonoF, RapaI, GiorcelliJ, PelleritoR, VolanteM, OrlandiF. 2014. Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features. Eur J Endocrinol, 170:659–666.
6.
VannucchiG, PerrinoM, RossiS, ColomboC, VicentiniL, DazziD, Beck-PeccozP, FugazzolaL. 2010. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol, 162:145–151.
7.
RakhlinL, FishS, TuttleRM. 2017. Response to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer. Thyroid, 27:396–401.
8.
KuyS, RomanSA, DesaiR, SosaJA. 2009. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg, 144:399–406; discussion 406.
9.
Stagnaro-GreenA, AbalovichM, AlexanderE, AziziF, MestmanJ, NegroR, NixonA, PearceEN, SoldinOP, SullivanS, WiersingaW. 2011. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid, 21:1081–1125.
10.
ItoY, MiyauchiA, KudoT, OtaH, YoshiokaK, OdaH, SasaiH, NakayamaA, YabutaT, MasuokaH, FukushimaM, HigashiyamaT, KiharaM, KobayashiK, MiyaA. 2016. Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital. Thyroid, 26:156–160.
11.
KandilE, KrishnanB, NoureldineSI, YaoL, TufanoRP. 2013. Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. ORL J Otorhinolaryngol Relat Spec, 75:6–17.
12.
AlexanderEK, MarquseeE, LawrenceJ, JarolimP, FischerGA, LarsenPR. 2004. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med, 351:241–249.
13.
LohJA, WartofskyL, JonklaasJ, BurmanKD. 2009. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid, 19:269–275.
HaugenBR, AlexanderEK, BibleKC, DohertyGM, MandelSJ, NikiforovYE, PaciniF, RandolphGW, SawkaAM, SchlumbergerM, SchuffKG, ShermanSI, SosaJA, StewardDL, TuttleRM, WartofskyL. 2016. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 26:1–133.
16.
American Thyroid Association Taskforce on Radioiodine Safety, SissonJC, FreitasJ, McDougallIR, DauerLT, HurleyJR, BrierleyJD, EdinboroCH, RosenthalD, ThomasMJ, WexlerJA, AsamoahE, AvramAM, MilasM, GreenleeC. 2011. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association. Thyroid, 21:335–346.
17.
HyerS, PrattB, NewboldK, HamerC. 2011. Outcome of pregnancy after exposure to radioiodine in utero. Endocr Pract. 1–10.
18.
WuJX, YoungS, RoK, LiN, LeungAM, ChiuHK, HarariA, YehMW. 2015. Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer. Thyroid, 25:133–138.
19.
SiokaC, FotopoulosA. 2011. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Fertil Steril, 95:1552–1559.
20.
SawkaAM, LakraDC, LeaJ, AlshehriB, TsangRW, BrierleyJD, StrausS, ThabaneL, GafniA, EzzatS, GeorgeSR, GoldsteinDP. 2008. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors. Clin Endocrinol (Oxf), 69:479–490.
21.
PapaleontiouM, BanerjeeM, YangD, SissonJC, KoenigRJ, HaymartMR. 2013. Factors that influence radioactive iodine use for thyroid cancer. Thyroid, 23:219–224.
